Uli Hacksell
2017 - Avalo Therapeutics
In 2017, Uli Hacksell earned a total compensation of $553.1K as Former President and Chief Executive Officer at Avalo Therapeutics, a 68% decrease compared to previous year.
Compensation breakdown
| Option Awards | $67,192 |
|---|---|
| Salary | $439,577 |
| Other | $46,350 |
| Total | $553,119 |
Hacksell received $439.6K in salary, accounting for 79% of the total pay in 2017.
Hacksell also received $67.2K in option awards and $46.4K in other compensation.
Rankings
In 2017, Uli Hacksell's compensation ranked 11,488th out of 14,666 executives tracked by ExecPay. In other words, Hacksell earned more than 21.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,488 out of 14,666 | 22nd |
Division Manufacturing | 4,503 out of 5,772 | 22nd |
Major group Chemicals And Allied Products | 1,641 out of 2,075 | 21st |
Industry group Drugs | 1,356 out of 1,731 | 22nd |
Industry Pharmaceutical Preparations | 1,059 out of 1,333 | 21st |
Source: SEC filing on April 5, 2018.
Hacksell's colleagues
We found five more compensation records of executives who worked with Uli Hacksell at Avalo Therapeutics in 2017.
2017
Ronald Marcus
Avalo Therapeutics
Chief Medical Officer
2017
John Kaiser
Avalo Therapeutics
Chief Executive Officer
2017
Mariam Morris
Avalo Therapeutics
Chief Financial Officer
2017
Peter Greenleaf
Avalo Therapeutics
Chief Executive Officer
2017
Robert Moscato
Avalo Therapeutics